0
Correspondence |

A Controlled Trial, LSE vs Killed LSE, Is Needed—Reply

William H. Eaglstein, MD; Francisco Kerdel, MD; George Elgart, MD; Robert Kirsner, MD; Michelle Muhart, MD
Arch Dermatol. 2000;136(4):555-556. doi:.
Text Size: A A A
Published online

Extract

In reply

Our study was the first and only study comparing the effect of a tissue-engineered skin with an autograft. Each patient served as his or her own control, having their 3 donor sites treated with autograft, LSE (Apligraf; Organogenesis Inc, Canton, Mass), and polyurethane film. The LSE and autograft performed very similarly when placed on acute partial-thickness donor sites, both healing more rapidly than the site treated with polyurethane film. The autograft was, in fact, some of the same skin removed to make the donor site wound on which it was placed! As pointed out by Epstein, we did not prove that the living cells in the LSE played an active role in the healing process. The study was not designed to prove that living cells played an active role in the healing process. We also did not prove that living cells in the autograft played an active role in the healing process. Since both LSE- and autograft-treated acute partial-thickness wounds healed more rapidly than the occlusive film–treated sites, we might have fairly speculated that the living cells in the LSE and autograft accounted for the difference, although we did not make such a speculation.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
Jobs